Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2006 2
2007 5
2008 7
2009 3
2010 5
2011 9
2012 9
2013 4
2014 9
2015 12
2016 9
2017 12
2018 14
2019 10
2020 13
2021 11
2022 9
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
The Differential Translation Capabilities of the Human DHFR2 Gene Indicates a Developmental and Tissue-Specific Endogenous Protein of Low Abundance.
Bookey N, Drago P, Leung KY, Hughes L, MacCooey A, Ozaki M, Henry M, De Castro SCP, Doykov I, Heywood WE, Mills K, Murphy MM, Cavallé-Busquets P, Campbell S, Burtenshaw D, Meleady P, Cahill PA, Greene NDE, Parle-McDermott A. Bookey N, et al. Among authors: meleady p. Mol Cell Proteomics. 2024 Mar;23(3):100718. doi: 10.1016/j.mcpro.2024.100718. Epub 2024 Jan 14. Mol Cell Proteomics. 2024. PMID: 38224738 Free PMC article.
Development of a fast and simple method for the isolation of superparamagnetic iron oxide nanoparticles protein corona from protein-rich matrices.
Soliman MG, Trinh DN, Ravagli C, Meleady P, Henry M, Movia D, Doumett S, Cappiello L, Prina-Mello A, Baldi G, Monopoli MP. Soliman MG, et al. Among authors: meleady p. J Colloid Interface Sci. 2024 Apr;659:503-519. doi: 10.1016/j.jcis.2023.11.177. Epub 2023 Dec 2. J Colloid Interface Sci. 2024. PMID: 38184993
Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.
McDermott MSJ, Browne BC, Conlon NT, O'Brien NA, Slamon DJ, Henry M, Meleady P, Clynes M, Dowling P, Crown J, O'Donovan N. McDermott MSJ, et al. Among authors: meleady p. Mol Cancer. 2023 Oct 30;22(1):175. doi: 10.1186/s12943-023-01890-z. Mol Cancer. 2023. PMID: 37915024 Free PMC article. No abstract available.
140 results